T
Tisha Wang
Researcher at University of California, Los Angeles
Publications - 67
Citations - 1275
Tisha Wang is an academic researcher from University of California, Los Angeles. The author has contributed to research in topics: Medicine & Pulmonary alveolar proteinosis. The author has an hindex of 17, co-authored 56 publications receiving 872 citations. Previous affiliations of Tisha Wang include UCLA Medical Center & University of Southern California.
Papers
More filters
Journal ArticleDOI
Pulmonary alveolar proteinosis.
Bruce C. Trapnell,Koh Nakata,Francesco Bonella,Ilaria Campo,Matthias Griese,John A. Hamilton,Tisha Wang,Cliff Morgan,Vincent Cottin,Cormac McCarthy +9 more
TL;DR: Pulmonary alveolar proteinosis comprises a group of diseases with different pathogenetic mechanisms but a common outcome — the progressive accumulation ofAlveolar surfactant in the lungs and dysfunction of alveolars macrophages, which result in respiratory failure and increased risk of secondary infections.
Journal ArticleDOI
Targeting GM-CSF in COVID-19 Pneumonia: Rationale and Strategies.
Aldo Bonaventura,Aldo Bonaventura,Alessandra Vecchié,Tisha Wang,Elinor Lee,Paul Cremer,Brenna Carey,Prabalini Rajendram,Kristin M. Hudock,Kristin M. Hudock,Leslie Korbee,Benjamin W. Van Tassell,Lorenzo Dagna,Antonio Abbate +13 more
TL;DR: Initial findings from patients with COVID-19 treated with a single intravenous dose of mavrilimumab, a monoclonal antibody binding GM-CSF receptor α, showed oxygenation improvement and shorter hospitalization, will help inform whether blunting the inflammatory signaling provided by the GM- CSF axis in CO VID-19 is beneficial.
Journal ArticleDOI
Subsequent Infections in Survivors of Sepsis: Epidemiology and Outcomes
TL;DR: Critically ill patients who survive sepsis have an increased risk of recurrent infections in the year following their septic episode that is associated with increased mortality.
Journal ArticleDOI
A narrative review: The effects of opioids on sleep disordered breathing in chronic pain patients and methadone maintained patients.
TL;DR: CSA and OSA are common in MMPs and chronic pain patients on opioids, and higher opioid doses appear to be a risk factor for CSA, and to a lesser extent OSA.
Journal ArticleDOI
Molecular and cellular aspects of sepsis-induced immunosuppression.
Tisha Wang,Jane C. Deng +1 more
TL;DR: An overview of the clinical and experimental evidence for sepsis-induced immunosuppression is presented and the mechanisms that underlie this phenotype are outlined.